Tuberculosis (HIV-negative people) - Wikidata - wikimedia - TriplyDB

Tuberculosis (HIV-negative people)

Tuberculosis (HIV-negative people)

http://www.wikidata.org/entity/Q56836949

about

Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses

P2860

Q28481610-738D328D-DB80-4F7D-9208-43293D19F11A

P2860

Tuberculosis (HIV-negative people)

http://www.wikidata.org/entity/Q56836949

description

article

@en

im April 2009 veröffentlichter wissenschaftlicher Artikel

@de

наукова стаття, опублікована у квітні 2009

@uk

name

Tuberculosis (HIV-negative people)

@en

type

label

Tuberculosis (HIV-negative people)

@en

prefLabel

Tuberculosis (HIV-negative people)

@en

P1433

Q56836949-A72C2EAE-45F2-41EB-9EE9-46205C4605E0

P1476

Q56836949-4E998B47-58FC-4669-8595-A237EC9D6345

P2093

Q56836949-CA82CE2F-64B8-45A2-AB47-F7B098FA0408

P2860

Q56836949-0EB3EB30-2ACD-4C99-B090-E3B21A5E55FE

Q56836949-113A7252-C675-4B70-AC9D-A875242AD294

Q56836949-278B5C1E-C6D2-4407-A33D-2F957ACFFD9C

Q56836949-297BAF2D-CABD-45E3-B462-EADFD88B8913

Q56836949-2FD35604-6E67-4201-AB8D-8647A034DF75

Q56836949-32BD718A-E513-42D3-B7EB-2E4F53FCF86C

Q56836949-4C57D841-587B-4A69-B7D1-1E03F262362B

Q56836949-59BFA91A-D7CE-4DE2-B5AB-56953C428F00

Q56836949-64C1F901-6C2F-4981-A804-52870F3F6BC7

Q56836949-6554726E-C97F-41B9-AF8F-9086D61C7949

P31

Q56836949-01909856-85A6-4FBD-BE36-A5556616BC3E

P407

Q56836949-E71674AD-B447-4A69-9162-FAC752AD6BF3

P478

Q56836949-7C895711-51B9-46D7-AB81-E902C7C97266

P50

Q56836949-1B27F2F1-E753-4906-A70F-9BFB73A43CED

P577

Q56836949-2088B48C-5AB5-4F05-82C8-45269009E8F8

P698

Q56836949-28B53571-1581-4788-A863-39AD57FCFE9A

P932

Q56836949-387E8D07-A260-427C-AABF-7EAAAF5430CB

P1433

Clinical Evidence

P1476

Tuberculosis (HIV-negative people)

@en

P2093

Lilia E Ziganshina

http://www.w3.org/2001/XMLSchema#string

P2860

Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis

Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis

Controlled clinical trial of 4 short-couse regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis

A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society

Role of gallium arsenide laser irradiation at 890 nm as an adjunctive to anti-tuberculosis drugs in the treatment of pulmonary tuberculosis.

Incentives vs outreach workers for latent tuberculosis treatment in drug users.

Isoniazid preventive therapy and risk for resistant tuberculosis.

Long term efficacy of DOTS regimens for tuberculosis: systematic review.

Fluoroquinolones for the treatment of pulmonary tuberculosis.

Effectiveness of a strategy to improve adherence to tuberculosis treatment in a resource-poor setting: a cluster randomized controlled trial.

P31

scholarly article

P407

P478

2009

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19445749

http://www.w3.org/2001/XMLSchema#string

P932

2907790

http://www.w3.org/2001/XMLSchema#string